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Abstract
Background: Patient-controlled analgesia (PCA) administration of opioids is associated with
risk for respiratory depression. Capnography is a non-invasive way to identify early respiratory
depression and prevent adverse patient events.
Purpose: This project evaluated the effectiveness of capnography versus standard monitoring in
reducing adverse events among patients admitted to an intensive care unit (ICU) who were
prescribed PCA opioids and evaluated patients at high-risk for respiratory depression according
to age, gender, diagnosis, co-morbidities, and type of opioid prescribed.
Methods: This project used a pre- and post-intervention design to compare differences in the
number of adverse events among 20 adult patients admitted to an ICU during a six-month period
who were prescribed PCA opioids and received either capnography monitoring or standard
monitoring. A chi-square test was conducted to evaluate group differences.
Results: The number of adverse events was not significantly different between patients who
received standard monitoring versus those who received capnography (X2=0.00, df=1, N=20,
p>0.05). Adverse events were not significantly associated with age, gender, number of comorbidities, type of opioid, and diagnosis (p>0.05).
Conclusions: Implementation of capnography among ICU patients on PCAs did not decrease the
number of adverse events. However, there were favorable trends noted with regards to sedation
level and a decrease in the occurrence of bradypnea in patients receiving capnography. Results
from this project will guide the implementation of capnography throughout the institution.
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Introduction
Opioids used for pain control are recognized to be a main factor for respiratory depression
(The Joint Commission, 2012) and account for a rising number of patient deaths in hospitals.
This has raised alarm from both The Joint Commission (TJC) (2019) and the Institute for Safe
Medication Practices (ISMP) (2009, 2013). The risk for respiratory depression increases with
the use of patient-controlled analgesia (PCA) and frequent administration of high doses of
opioids without PCA (ISMP, 2013). This increased mortality results from failure to recognize
some patients at high risk for respiratory depression with opioid administration and lack of close
monitoring of these same patients.
Professional organizations suggest institutions define patient characteristics that are
associated with a high-risk for respiratory depression based on their community’s population
(American Society of Anesthesiologists (ASA), 2018; Jarzyna, et. al., 2011). These same
organizations, as well as TJC and ISMP, encourage hospitals to develop policies and procedures
for monitoring all patients receiving opioids, particularly those at high-risk for respiratory
depression, and to use technology to assist with monitoring. Capnography detects early
respiratory failure and is a sensitive tool for identifying respiratory depression before vital sign
and sedation level deterioration.
This evidenced-based practice (EBP) project compared capnography monitoring versus
standard monitoring among patients prescribed epidural or intravenous (IV) PCAs or high doses
of opioids and evaluated the number and type of adverse events including rates of hypercapnia
and/or hypoxia, hypotension, sedation level, and bradypnea. This project also evaluated the
impact of age, gender, diagnosis, type of opioid prescribed, and number of co-morbidities on the
number of adverse events to identify patient characteristics associated with a high risk for
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respiratory depression and define criteria for capnography monitoring. The project informed the
development of criteria for capnography monitoring for patients receiving opioids at an academic
research hospital and provided evidence to guide the development of policies, procedures, and
education for nursing and medical professionals when capnography is implemented throughout
the hospital.
Significance
The risk of death from respiratory depression due to opioid therapy increases with the use of
patient-controlled analgesia (PCAs). In 2008, an analysis of 500 hospitals revealed that 6.5% of
PCA errors caused patient harm, as compared with 1.5% general medication errors (Hicks,
Sikirica, Nelson, Schein, Cousins, 2008). In a retrospective review of national, multiinstitutional post-operative opioid overdose, Cauley, et. al. (2017) described that the frequency of
overdose doubled from 0.6 to 1.1 per 1000 cases from 2002 to 2011. The authors concluded that
recognition of patients who were at high risk for overdose and implementation of proper
monitoring should be employed to prevent fatalities. In 2012, TJC issued a sentinel alert advising
hospitals to implement policies for the early assessment of opioid induced respiratory depression.
The Joint Commission has no specific monitoring recommendations other than identifying
patients as high risk and implementing evidenced based guidelines (TJC, 2019). The ISMP
recommends regular interval monitoring of vital signs, physical assessment, pain and sedation
assessment, and monitoring of respiratory status using technology (ISMP, 2013). Capnography is
a sensitive method for measuring ventilation and respiratory rate. It can provide early warning of
respiratory failure hours before pulse oximetry detects oxygen desaturation (Burton, Harrah,
Germann, & Dillion, 2006; Kopka, et. al., 2007). Implementing capnography has the potential to
detect respiratory deterioration early in order to institute measures to prevent respiratory
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depression, improve outcomes, and decrease adverse events among patients receiving PCA and
opioids in the ICU.
Background
Capnography is a sensitive technology used for identifying normal oxygen exchange.
Capnography, or end tidal carbon dioxide (ETCO2) monitoring, detects levels of carbon dioxide
in a person’s blood. Normal ETCO2 levels are between 35-45 mm Hg. High levels of ETCO2
are called hypercapnia and indicate that the person is retaining carbon dioxide. This happens
with depressed respiratory rate. Capnography has the advantage of detecting early respiratory
depression as the ETCO2 will start to rise before the oxygen level in the blood begins to fall
(Jarzyna, et. al., 2011; Burton, Harrah, Germann, & Dillion, 2006; Kopka, et. al., 2007)
In 2017, the Surgeon-in-Chief at the institution where this project was implemented
requested that capnography be employed as a non-invasive way to identify early respiratory
depression for patients on both epidural and intravenous patient-controlled analgesia (PCA). The
current process for monitoring all patients in the ICU consists of continuous vital sign
monitoring, including pulse oximetry, and sedation level. Pain and sedation are assessed every
four hours or more frequently if the patient is not achieving satisfactory pain control or if there
are rate changes to the PCA or extra doses of opioids administered for those not on a PCA.
Capnography monitoring is currently not routinely used for patients on PCAs or receiving
opioids in the ICU.
At the same time as the Surgeon-in-Chief’s request, the institution underwent a voluntary
survey by the ISMP. The ISMP recommended utilizing advanced technology, such as
capnography, for recognizing early respiratory depression for patients on PCAs. Although vital
sign and sedation monitoring is crucial, capnography is a more sensitive method to recognize
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early respiratory depression. Based on both the Surgeon-in-Chief’s’ request and the ISMP
recommendations, the Oncology Clinical Nurse Specialist was charged with researching best
practices and tools for detecting early respiratory depression in patients receiving opioids
through a PCA.
It was agreed at the outset of this initiative that it would not be necessary for every patient on
a PCA or receiving opioids in the hospital to be placed on capnography based on the recognition
that not all patients would be at high risk for respiratory depression. Therefore, following
recommendations from professional organizations (ISMP, 2013; ASA, 2018; Jarzyna,et. al.,
2011), defining the characteristics of what makes a patient who is prescribed opioids as “highrisk” for respiratory depression is of interest to the organization where this project was
conducted. It was also pointed out by the pediatricians and pediatric nurses that children do not
tolerate the large nasal cannula used for capnography. Currently, children at this institution on
PCAs and receiving high doses of opioids are monitored using continuous pulse oximetry.
Therefore, children were excluded from this project. A group of stakeholders met in 2017 to
determine the criteria which would qualify a patient as high-risk for respiratory depression with
opioid use and thus require capnography monitoring. The original stakeholder group consisted of
practitioners from the Pain and Palliative Service, surgeons, physicians, and nurse practitioners
from service areas outside of surgery, plus Clinical Nurse Specialists and nurses from across the
hospital. The final criteria developed focused exclusively on dosages of opioids and adjunct
medications prescribed; patient characteristics such as age and co-morbidities that could also
qualify a patient as high-risk were assumed left to the discretion of the prescriber or nurse.
Based on the work done by the stakeholder group, a pilot project was proposed to implement
and evaluate capnography monitoring in the ICU before deploying this equipment to the entire
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hospital. The results of this EBP project will contribute to final policy and procedure development.
This project added important elements for the development of nursing and practitioner education
through the experience of the staff in the pilot unit. It identified technological issues that will
impact delivery of care. With publication of results, the project could help other institutions decide
if implementation of capnography monitoring would be beneficial for their patient population.
Needs Assessment
A Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis of barriers and
facilitators for this initiative was conducted (see Appendix A). The implementation of
capnography monitoring in the ICU for patients at high-risk for respiratory depression from
opioids had strong support from medical and nursing leadership at the institution. Facilitators
included a group of stakeholders with expertise in pulmonary medicine and pain management
among medicine, nursing, respiratory therapy, and pharmacy. Guidance from accrediting
organizations concerned with patient safety and evidence in the literature also provided
validation of the need for using technology to improve assessment in patients receiving opioids
(TJC, 2019; ISMP, 2009, 2013). Capnography has been demonstrated through randomized
controlled studies to be superior in providing non-invasive monitoring for early respiratory
depression (Deitch, et. al., 2010; Friedrich-Rust, et. al., 2014; Li, et. al., 2018). New vital sign
machines with capnography capability have been purchased for units outside of the ICU. End
tidal carbon dioxide will be able to be monitored outside of the ICU for patients on PCAs or
receiving high doses of opioids and at risk for respiratory depression. This has the advantage of
allowing nurses to perform “softer” interventions such as withholding the narcotic or repositioning rather than administration of naloxone or other rescue measures. Other facilitators
included a robust nursing shared governance model that is committed to implementing best
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evidenced based practice in the care of our patients. Nurses newly employed by the Clinical
Center also bring experience from the community and champion best practices. A strong nursing
education department and CNS group who are engaged with the nurses can quickly develop
education plans and competencies to enhance nursing practice of patients receiving opioid or
narcotic infusions.
Barriers included concerns from our cybersecurity department about hacking into informatic
systems. The capnography equipment will be wireless, requiring the informatics security
department to fully test the wireless functionality for breeches interfacing with the medical
records informatic enterprise. Other barriers included agreement on the definition of patients
considered high risk for respiratory depression and based on long tenured practitioners, some
may not be up to date on current practice. There is also the possibility for resistance to placing
patients on capnography due to the fear that capnography would interfere with research
interventions. Continued assurance that this intervention will not interfere with research
objectives while ensuring ongoing best clinical care of the patient is necessary to prevent
derailment of this initiative.
Problem Statement
Currently, patients in the ICU on PCAs and opioids are not monitored with capnography.
Implementing capnography monitoring for ICU patients on PCAs and opioids had the potential
to decrease the incidence of adverse events and identify patients who would most benefit from
this level of monitoring.
Use of naloxone from January 2019 through May 2020 throughout all units of this institution
to treat respiratory depression secondary to opioids had been 37 occurrences. Detection of early
respiratory depression using capnography allows prescribers and nurses to intervene with less
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invasive interventions before requiring the administration of naloxone. It allows the nurse to
perform interventions such as repositioning and/or decreasing or withholding opioid doses before
administration of naloxone as this antidote is not without adverse effect.
Purpose Statement
The purpose of this project was to evaluate the effectiveness of capnography versus standard
monitoring to improve outcomes among patients admitted to an intensive care unit (ICU) who
were prescribed patient-controlled analgesia (PCA) or high doses of opioids and were considered
at high risk for respiratory depression.
Aims and Objectives
The aims for this project were to:
1.

Implement capnography monitoring for all ICU patients on PCAs and high doses of
opioids beginning September 8, 2020 through December 1, 2020.

2. Conduct a retrospective chart review to create a data set with outcomes for ICU patients
on PCAs and high dose opioids who received standard monitoring for 3 months prior to
implementation of capnography.
3. Compare differences in number of adverse patient events (defined as hypercapnia and/or
hypoxia, decreased sedation, bradypnea, hypotension) between ICU patients on PCAs or
high doses of opioids monitored with capnography versus standard monitoring by
December 31, 2020.
4. Compare differences in number of episodes of adverse patient events (hypercapnia,
hypoxia, hypotension, decreased sedation level, bradypnea) as well as variation in age,
sex, diagnosis, co-morbidities, and type of opioid between ICU patients on PCAs or high
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dosages of opioids to better define high-risk for respiratory depression versus not highrisk by December 31, 2020.

Objective for this EBP initiative included:
1. Decrease in adverse respiratory events in adult high-risk patients in the ICU who received
PCAs or high doses of opioids to zero during the 3-month period after implementation of
capnography by December 2020.
2. Analyze data and use project findings to inform the development of policies and
procedures for capnography monitoring for patients on PCAs or receiving opioids by
January 2021.
Literature Review
A literature search was conducted on September 10, 2019 to determine if capnography was
superior at detecting early respiratory depression as opposed to pulse oximetry, a measurement
of oxygen saturation, in patients receiving moderate sedation and/or opioids. The literature
search was conducted with the assistance of one of the research librarians at the institution in
which this project was implemented. Databases searched were PubMed, Medline, CINAHL,
Google Scholar, and Web of Science. Terms used for the literature search, which included
Boolean terms, were “capnography”, “capnography monitoring AND opioids”, “capnography
AND moderate sedation”, “capnography/or analgesia”, “capnography/or anesthesia” and “end
tidal CO2”. MeSH terms for PubMed were applied including “capnography” “analgesia” and
“monitoring”. Limits for the search included articles no older than 15 years and articles
published in English or translated into English. The search yielded a total of eight usable articles
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(Campbell, et. al., 2016; Deitch, Miner, Chudnofsky, Dominici & Latta, 2010; Friedrich-Rust, et.
al., 2014; Gupta, et. al., 2018; Jarzyna, et. al., 2011; Mehta, et. al., 2016; Li, et. al., 2018; Sites,
Surprise, McNeil, Northrop & Ruyter, 2017). (See Appendices B and C)
Inclusion criteria for the search included 1) Use of capnography, 2) Adult population greater
than 18, 3) Moderate sedation or patient controlled analgesia, 4) Articles published in English 5),
Articles published in the last 15 years, 6) Randomized controlled trials, 7) Position
statements/Clinical Practice Guidelines from professional organizations, and 8) Systematic
Reviews.
Since capnography is also used in intensive care units and the operating room, exclusion
criteria included the use of capnography in clinical areas where it is standard of practice. This
includes 1) Use of capnography in operating rooms, 2) During resuscitative events and 3) During
intubation or endotracheal tube placement. Also excluded were opinion papers and case reports.
All randomized controlled studies but two found monitoring for respiratory compromise with
capnography technology was superior to other forms of non-invasive monitoring. Several trials
found that patients who received capnography monitoring, as opposed to continuous pulse
oximetry, had fewer events of hypoxemia, hypoventilation, and earlier detection of respiratory
compromise (Deitch, et. al., 2010; Friedrich-Rust, et. al., 2014; Li, et. al., 2018; Stites, et. al.,
2017). A systematic review by Gupta, et. al. (2018) found that monitoring with pulse oximetry
and capnography, as well as sedation level, resulted in decreased respiratory adverse events for
patients defined as high-risk. This study identified common factors that put a patient at high-risk
of respiratory depression. Common factors in the studies that put a patient at higher risk of OIRD
included preoperative gabapentin or sustained release oxycodone, time from surgery (first 24
hours after surgery (in PACU), with a predominance in the first 12 hours), age (>60 years), sex
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(female) and comorbidities such as obstructive sleep apnea, cardiac disease, obesity, two or more
comorbidities, and opioid dependence. Professional organizations, including the American
Society of Anesthesiologists, American Society for Pain Management Nursing and ISMP
endorse capnography as the most sensitive method for non-invasive monitoring of ventilation.
Although capnography is a sensitive method for detecting impaired ventilation, two of the
randomized controlled trials found that frequent monitoring of sedation level, pulse oximetry,
and vital signs was as effective as capnography in obtaining safe outcomes for the patient. The
studies by Campbell et. al. (2016) and Mehta, et. Al., (2016) were randomized controlled trials
that enrolled patients older than 16 years of age undergoing procedural sedation. The researchers
found no differences in clinical outcomes between those receiving frequent monitoring versus
those patients receiving capnography. Though capnography detected hypoxia earlier than pulse
oximetry alone, the researchers concluded that frequent monitoring of sedation, vital signs and
pulse oximetry was as effective as capnography monitoring.
Conversely, other studies found added value when capnography was utilized during moderate
sedation. Dietch, et. al. (2010) found a 15% decrease in the incidence of hypoxia with use of
capnography versus standard monitoring in participants who were receiving propofol in an
emergency department. Friedrich-Rust, et. al., (2014) found parallel results when using propofol
for patients undergoing colonoscopy or colonoscopy plus endoscopy. Patients in the
capnography group experienced fewer episodes of hypoxemia (18% vs. 32%). Li, et. al. (2018)
studied women who were receiving propofol while undergoing lumpectomy. This study
replicated the above studies in that the control group received standard monitoring plus ETCO2
monitoring that could be visualized by the provider. The researchers found that CO2 retention
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was lower in the control group, episodes of apnea occurred less frequently in the control group,
and women who had ETCO2 monitoring had shorter recovery times.
Use of capnography allows nurses to intervene early on recognition of opioid induced
respiratory depression. Stites, et. al., (2017) studied nurses’ recognition of increased CO2 levels
and actions taken to correct impending respiratory distress. This study looked at the number of
rapid response calls (RRT) for opioid induced respiratory depression in patients who received
opioids through a PCA before and after hospital wide implementation of capnography for all
patients on PCAs. They found that the number of RRTs decreased after implementation of
capnography (0.04% pre-intervention vs. 0.02% post-intervention) indicating that nurses were
identifying opioid induced respiratory depression early.
Many studies support the use of capnography as a sensitive way to monitor for early
respiratory depression. A systematic review by Gupta, et. al. (2018) was conducted that
summarized risk factors of opioid induced respiratory depression in the postoperative period and
monitoring interventions that decreased adverse events. The review comprised 13 studies with
871,912 surgical patients. Monitoring of sedation level, pulse oximetry and capnography in
patients at risk of opioid induced respiratory depression (OIRD) decreased adverse respiratory
events. The authors recommended that monitoring ETCO2 and oxygen saturation coupled with
assessment of risk factors listed above will decrease adverse events in post-operative patients.
Finally, the American Society of Pain Management Nursing (ASPMN) agrees with the ISMP,
The Joint Commission, American Society of Anesthesiologists (2018), and other agencies
concerned with patient safety that capnography can provide early detection of respiratory
compromise in a high-risk patient thus allowing nurses to intervene before cardiac arrest
(Jarzyna, et.al., 2011). Their published position statement was based on extensive review of the
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literature, external peer review of applicability, and accuracy of the literature. Based on review
of the literature, risk factors of OIRD are divided into four categories: Individual risk, iatrogenic
risk, pharmacology, and monitoring capabilities. The ASPMN acknowledges that the cost of
capnography equipment, diverse patient populations, training of nursing staff, and non-consensus
of monitoring frequency are challenges when interpreting guidelines.
Evidenced Based Translation Model
The model that was selected for this project was the Rosswurm and Larrabee model
(Rosswurm & Larrabee, 1999). The purpose of this model is to integrate evidenced based
practice into care and move away from traditional practice models. The model consists of six
steps: Assess the need for change, link outcomes, synthesize the evidence, design the practice
change, implement, and integrate and maintain (see Appendix D). This model mirrors the
practice of a Clinical Nurse Specialist (CNS). It is a linear model that allows for in-depth
analysis at each step. The details surrounding this model for the project include:
1. Assess need for change in practice: The need for more sensitive monitoring for patients
on PCAs and receiving escalating doses of opioids had been identified. A group of
stakeholders from different specialty areas met. Data regarding adverse events was
reviewed at the initial meeting and the need for improvement in our practice was
identified.
2. Link outcomes: Outcomes for the implementation of capnography monitoring were
identified. Rapid response calls and events surrounding respiratory depression with
opioids (naloxone use) in the post-anesthesia care unit were discussed. Though the
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history of adverse events has been low for patients on PCAs, these events were discussed
with the goal towards avoiding future events.
3. Synthesize evidence: A literature search was conducted. At issue in the literature was
the need for defining the “high risk” patient who would benefit from capnography. Over
30 definitions of “high risk” were discovered in the literature. Including all these
definitions was neither feasible nor realistic for our population.
4. Design the practice change: In light of all the definitions, the stakeholder group reconvened and decided on the definition of “high risk” for the population that we see at
the NIH.
5. Implementation: This pilot project was conducted in preparation for implementation to
the rest of the hospital. Nursing policy was updated and education was planned while
awaiting final details on arrival and installation of the equipment. Order sets and a
medical policy were developed. A final definition of high-risk will be decided upon after
review of the findings from this pilot project. Flow sheets will be revised in the future so
that nurses have a place to document capnography monitoring.
6. Integrate and Maintain: Policy and procedures will either need to be created or revised
once this project is implemented hospital wide.. Whether this change will be integrated
into existing nursing policy on non-invasive ventilation, or a medical policy created or
revised will need to be decided upon by nursing and medical leadership. Staff education
will need to be developed as well. Ongoing, implementation of this new process will
need to be evaluated to include patients defined as high-risk, nursing and licensed
independent practitioner ongoing education and competency validation, and identification
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of equipment issues such as, the number of false alarms. Process and clinical outcome
measures will need to be developed to assure that new technology and criteria are being
used appropriately, and clinical outcomes demonstrate improvement. Documentation
standards and practices will need to be evaluated for consistency.
Methodology
This EBP project implemented and evaluated the effectiveness of capnography versus
standard monitoring for improving outcomes among adult ICU patients (defined as aged 18 years
or older) on PCAs or receiving opioids. The project design was a pre-and post-intervention
comparison of outcomes for ICU patients on PCAs who received standard monitoring over a
three-month period compared with those patients who received capnography monitoring for a 3month period. During implementation of the project, all patients on IV or epidural PCA or those
not on PCA but meeting high risk criteria (use of two or more pain control or adjunct agents
simultaneously or frequent escalating doses of oral or IV intermittent narcotics) were placed on
capnography.
Data was entered into the Statistical Package for Social Sciences (SPSS) software for data
analysis. The final sample size was 20 patients: 10 patients in the “Retrospective” sample
(hereafter referred to as the “standard monitoring group”) and 10 patients in the
“Implementation” (referred to as the “capnography group”) sample. The spreadsheet was sent to
the primary and secondary project advisors, for review of data accuracy. There were no outliers
or missing data.
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Setting
The setting for this project was a 12-bed ICU in an academic research hospital in the MidAtlantic region. This ICU is the only ICU in the hospital and admits medical and surgical
patients, including pediatrics.
The ICU has capnography equipment installed and the nurses are experts at interpreting
capnography as part of standard critical care competency. Capnography is currently not used
routinely on ICU patients who are administered opioids or prescribed PCAs. This form of
monitoring is typically only used post-resuscitation for up to 24 hours.
Participants
Eligibility criteria for inclusion in this project for both the standard monitoring and
capnography groups included adult patients over the age of 18 who were prescribed either an IV
or epidural PCA or opioids administered by another route. Exclusion criteria included those who
received sedation due to critical illness and patients who received end of life care. Patients who
received sedation due to intubation or critical illness were excluded as they were too critically ill
to differentiate if adverse events were due to the opioids or illness.
Recruitment
The sample for this project was a convenience sample of patients admitted to the ICU during
the project period who met eligibility criteria.
Risk/Harms
Risk with using capnography is minimal. The nasal cannula is larger than an oxygen cannula
so it can be uncomfortable. This can prompt a patient to remove it. Also, cannulas can cause
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pressure injury to the ears and nose. Like an oxygen cannula, nurses assessed for pressure
injuries caused by devices as part of regular assessment.
Cost and Compensation
Budget requirements were non-existent. Capnography equipment is already installed in the
ICU. The ICU nurse educator and CNS provided support for this project and were able to
provide ongoing assistance with education of capnography monitoring. The project did not
require extra staff support for implementation. Patients were not compensated for their
participation.
Interventions
Standard Monitoring Group: A retrospective chart review was conducted to identify all ICU
patients prescribed PCAs or opioids three months before implementation of capnography from
June through August 2020. These ICU patients received standard monitoring. Standard
monitoring consisted of continuous vital sign monitoring including continuous pulse oximetry,
pain assessment every four hours, and continuous sedation assessment. Capnography in the ICU
during this time period was only used for post-resuscitative events for approximately 24 hours; it
was not routinely used for patients receiving PCAs or opioids. Data collection from these
patients includes the variables listed in Appendix E.
Capnography Group: Before the implementation phase of the project began, a meeting was
called with the medical, nursing, pharmacy, and respiratory staff to describe the project. All
patients admitted to the ICU for three months of the intervention period, September through
December 8, 2020, on IV or epidural PCAs or those meeting high risk criteria not on PCA (use
of two or more pain control or adjunct agents simultaneously or frequent escalating doses of oral
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or IV intermittent narcotics) were placed on capnography (Appendix F). In addition to the
capnography monitoring, all patients received standard monitoring as described above.
Monitoring equipment utilized in the ICU is the Philips MX800 critical care monitor. This
monitor consists of a bedside monitor next to each ICU bed, central monitors at the nursing
station and monitors at regular intervals along the upper wall in the hallway (4 hallway
monitors). Visualization of all patients can occur anywhere in the ICU main and overflow areas
(except the break room, conference room, bathroom, or offices). The central monitor can
accommodate up to 12 patients. The equipment measures pulse, respiratory rate, blood pressure,
oxygen saturation, and mean arterial pressure with waveforms through the arterial line. For
patients without an arterial line and for emergencies in case the arterial line is not functioning
well, a blood pressure cuff is placed on the patient and inflated at intervals determined by the
nurse and physician to measure blood pressure, pulse, and mean arterial pressure. Oxygen
sensors can be placed on fingers, toes, or ears to capture oxygen saturation for those without an
arterial line. The monitors record cardiac rhythm through a five-lead electrocardiogram
monitoring system. End tidal carbon dioxide (ETCO2) is measured through a nasal cannula
designed for ETCO2 measurements. This cannula connects into the monitoring equipment at the
bedside to capture values. All patient measurements are continuously recorded and electronically
interfaced with the critical care medical record at hourly intervals. All monitors automatically
default to the normal value of ETCO2 35-45mmHg and for the purposes of this project, the
normal ETCO2 values of 35-45mmHg were utilized.
Outcomes Measured
Outcomes measured included the number and type of adverse events defined as
hypercapnia (if on capnography), hypotension, hypoxia, sedation level, and bradypnea.
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Hypercapnia was defined as an ETCO2 greater than 45mmHg. Hypotension was defined as a
blood pressure <90/60. Hypoxia was defined as an oxygen saturation less than 90 percent.
Respiratory rate that was considered an indication of respiratory depression is less than 12
breaths per minute. Sedation level was monitored using the sedation scale associated with the
institution’s pain scale ranging from alert and oriented to hallucinating/confused to unarousable
(see Appendix E).
Measurement of pain utilized the Numeric Pain Rating Scale (McCaffery & Beebe, 1993).
This pain scale is a validated pain scale that is widely used throughout the United States. Patients
rate their pain from 0 (no pain) to 10 (worst pain). Pain and sedation level were assessed by the
nurses every four hours and recorded on the “Pain Flowsheet” in the chart. Medication
administration via PCAs was documented on both the Medication Administration Record (MAR)
and the PCA Flowsheet. When pain medication was administered or a non-pharmacologic
intervention to alleviate pain had been performed (such as a heat pack), pain was reassessed
within 60 minutes of the intervention. If the patient continued to verbalize unsatisfactory pain
relief, the nurse intervened by either administering more pain medication based on orders from
the physician or performing a non-pharmacologic intervention. Administration of extra doses of
pain medication were recorded in the MAR and recorded in the PCA Flowsheet.
For patients who were not on PCAs, but prescribed more than one opioid, an opioid plus
adjunct medication to achieve satisfactory pain control or escalating doses of opioids, the patient
was placed on capnography. Only one patient in the capnography group met this criterion
(Appendix F).

CAPNOGRAPHY IMPLEMENTATION

22

Data Collection
The data and variables collected for this project are listed in the Data Dictionary (Appendix
E). All data was stored in SPSS software on a password protected computer. Each patient was
de-identified and assigned a random participant number and demographic data of age, gender,
diagnosis, co-morbidities, and reason for admission was collected from the patient chart. The
standard monitoring sample from the retrospective chart review was obtained with the assistance
of pharmacy who was able to generate a report of all patients on PCAs or receiving opioids in the
ICU for the three months specified. Data collection for both the standard monitoring and
capnography groups included date of data collection, assignment of participant number, age,
gender, procedure type or reason for ICU admission, diagnosis, type of PCA or receiving high
doses of opioids (not IV or epidural), number of and list of specific co-morbidities, adverse
events (if any) and nursing actions taken in response to the event, and capnography monitoring
(for the capnography group only). All data were retrieved from the medical record and the PI
rounded in the ICU daily to see patients and have conversation with the practitioners and nurses.
The ICU nurses and respiratory therapists use the electronic Critical Care Flowsheet to document
care and events. The Philips monitors automatically transfer information into the critical care
flowsheet hourly so patient measurements (including ETCO2) can be retrieved. There was no
missing data for this project.
Adverse events that occurred with the PCA and the interventions used to reverse the event
were recorded in the medical record. The nurses documented on all events within the Pain
Assessment and PCA flowsheets.
Data analysis
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Data analysis included descriptive statistics of the sample and variables (see Table 1,
Appendix F). After the descriptive statistics of the sample were completed, chi-square analyses
were performed to evaluate the impact of capnography monitoring. The independent variable
was capnography monitoring, and the dependent variables are adverse events defined as episodes
of hypoxia, hypercapnia, hypotension, bradypnea, and sedation level. Alpha was set at 0.05.
The final sample size consisted of 20 patients: 10 in the standard monitoring group and 10 in the
capnography group.
Timeline
This project took place from June through December 2020. Support for this project was
obtained from nursing and medical leadership in the ICU. Review of background of the project,
criteria for capnography with the high risk versus low-risk criteria (Appendix G), and normal
ETCO2 values were provided to nursing, respiratory therapists, and practitioner staff in the ICU.
Contact information for the investigator was provided in case of questions and the PI rounded in
the ICU at least daily Monday through Friday during the implementation period.
Resources Needed
Stakeholders for this project included the ICU leadership (nursing management and attending
physicians), ICU medical fellows, the nursing service educator for the ICU, respiratory therapists
in the ICU, the ICU pharmacists, and the nursing staff. Nursing, medical, and respiratory
therapy staff provided care as is routine in the ICU except for needing to manage the
capnography equipment and alarms. This increased the workload of the staff due to issues with
the nasal cannula (described in the Results section). The educator, CNS, managers, and charge
nurses for the ICU assisted in trouble shooting the equipment and helped identify patients for
whom capnography would be beneficial.
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Ethical Considerations
The capnography equipment is associated with minimal harm and this intervention is already
a standard of care in the community, so no research interventions were conducted. Identifiable
patient information was not collected for this project. The Institutional Review Board at the
project site deemed this project as exempt from board review due to minimal risk to subjects and
not a research intervention.
Security
All patients were de-identified and assigned a random number. All data was stored in SPSS
on a password protected computer.
Results
The purpose of this project was to evaluate the effectiveness of capnography versus standard
monitoring to decrease adverse events among patients admitted to the intensive care unit (ICU)
who were prescribed patient-controlled analgesia (PCA) or high doses of opioids and were
considered at high risk for respiratory depression. There were 10 patients who received
capnography and 10 patients who received standard monitoring. Most of the patients in both the
capnography and standard monitoring groups were over 55 years of age and male (60%). The
most common diagnosis was cancer (80%). Within the standard monitoring group half of the
patients had at least one co-morbidity. Within the capnography group, 90% of patients had at
least one co-morbidity. The descriptive statistics for the patients are reported in Table 1
(Appendix G).
Analysis of the data, using chi-square test of independence, showed no statistically
significant differences in the number of adverse events between those patients who were
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monitored with capnography and those who received standard monitoring, (X2(1, N=20) = 0.00,
p=1.00) (Appendix H, Table 2). Analysis of each of the aims of the study were as follows:
1. For Aim 1, capnography monitoring was implemented between September 8, and
December 1, 2020 for 10 ICU patients receiving intravenous, epidural PCAs or high
doses of opioids. There were 30% of the patients on capnography who had an adverse
event specifically, hypercapnia, hypoxia, hypotension, decreased sedation level, or
bradypnea during the implementation timeframe (Appendix I, Table 3).
2. For Aim 2, a retrospective chart review was conducted for June 2020 through August
2020, and 30% of 10 ICU patients on intravenous, epidural PCAs or high doses of
opioids who received standard monitoring had an adverse event including: Hypoxia,
hypotension, bradypnea, or decreased sedation level (Table 3).
3. Differences in number of episodes of adverse events between 10 ICU patients on PCAs
or high doses of opioids monitored with capnography versus 10 patients on standard
monitoring was compared with chi-square test of independence. There was no statistical
difference between the two groups, X2(1, N=20) = 0.00, p=1.00. (Table 2).
4. Differences in the number of episodes of hypercapnia, hypoxia, hypotension, decreased
sedation level, bradypnea (adverse patient events) was compared according to variation in
age, gender, diagnosis, and co-morbidities among ICU patients on PCAs or high dosages
of opioids using crosstabs comparison and chi-square test of independence for each
variable. Adverse events were not significantly associated with age, gender, number of
co-morbidities, type of opioid, and diagnosis (p>0.05) (Table 4, Appendix J). However, a
higher number of adverse events were observed in patients older than 55 years (30%),
those on epidural opioids (25%), females (20%), and those with two or more co-
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morbidities including lung/cardiac disease and a history of >20 pack year smoking
history (20%) (Table 4). Additionally, the percentage of patients with the occurrence of
different monitoring events related to blood pressure, carbon dioxide, oxygen saturation,
respiratory rate and sedation level are presented in Table 3 (See Appendix I).
Interestingly, the capnography monitoring group showed modest favorable trends
compared with the standard monitoring group related to respiratory rate and sedation
level. Specifically, there was a decrease in the percentage of patients who had a
respiratory rate less than 12 breaths per minute in the capnography group (20%)
compared with the standard monitoring group (30%). There was also a decrease in the
percentage of patients who were difficult to arouse in the capnography group (0%) versus
the standard monitoring group (10%).
Discussion
Many randomized controlled trials have demonstrated that capnography monitoring is
superior to monitoring with vital signs, pulse oximetry, and sedation level alone (standard
monitoring) in detecting early respiratory depression. Rising ETCO2 levels is a sensitive and
specific sign of respiratory distress and occurs before changes in vital signs or decrease in
oxygenation levels. Based on the results of these research studies, professional and regulatory
organizations recommend that sensitive technology be utilized as a method for detecting early
respiratory depression. Capnography is a non-invasive, sensitive mechanism for recognizing
changes in patient status before harm occurs.
The advantage of capnography monitoring is it allows nurses to perform interventions to
reverse respiratory depression before resorting to the administration of naloxone. The study by
Stites, et. al., (2017) demonstrated that the number of rapid response calls (RRT) for opioid
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induced respiratory depression in patients who received opioids through a PCA before and after
hospital wide implementation of capnography decreased. Naloxone is not without potential for
harm as not only does it cause a complete reversal of pain control but can cause adverse effects
along with the reversal of the opioid. These adverse effects can include the need to re-establish
adequate pain control and at the extreme, psychosis, arrhythmias, and cardiopulmonary arrest.
Use of “softer” nursing interventions to gently reverse the effect of the opioid would be
preferable to naloxone administration.
At issue is the type of patient who would be appropriate for capnography monitoring. Over
30 patient characteristics have been described within clinical trials that would warrant
consideration for capnography. Since it is not feasible that every patient at this institution would
require capnography monitoring, this project attempted to narrow criteria among our population
that would benefit from this type of intensive monitoring. Among characteristics identified in
the literature that were examined for the purposes of this project included patients older than 55
years, those with multiple co-morbidities including obstructive sleep apnea, smoking history
greater than 20 pack years and patients with a history of lung and/or cardiac disease. More
adverse events among these groups were observed during this project, further supporting which
patient type should receive capnography.
This project evaluated if capnography monitoring improved outcomes in terms of decreasing
adverse events among ICU patients who were receiving opioids through an epidural or
intravenous PCA, or high doses of opioids administered via other routes. A retrospective sample
of patients who received standard monitoring was evaluated for adverse events and compared
with patients who received capnography monitoring. The sample size and descriptive
characteristics for both groups were similar; there was no statistically significant difference in
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the number of adverse events for patients receiving capnography versus standard monitoring. In
addition, there were no significant differences in the number of adverse events with respect to
age, gender, opioid type, number of co-morbidities, and diagnosis. Although not statistically
significant, patients older than 55 years of age, females, those receiving epidural patientcontrolled analgesia, and those with two or more co-morbidities plus a history of lung or cardiac
disease, obstructive sleep apnea, or greater than a 20-pack year history of smoking, had more
observable adverse events. These findings indicate patient characteristics that may be associated
with a higher risk for respiratory depression. Implementing capnography monitoring among
patients with these identified risk factors may allow for early intervention to prevent
complications and adverse events.
Limitations of this study included the impact of the COVID-19 pandemic, the setting in which
this project was implemented (ICU), eligibility criteria for patient inclusion in the project, and
the nasal cannula equipment used for the capnography. The impact of the pandemic resulted in a
small sample size for both the standard monitoring and capnography implementation groups.
Patients diagnosed with COVID-19 admitted to the ICU were critically ill and therefore did not
meet eligibility criteria for inclusion in this project.
Secondly, all patients enrolled into the study were patients under ICU level care. Patient
observation in an ICU is closely monitored as all patients were connected to monitoring
equipment such as continuous vital sign monitoring. Nursing care was also provided under a
one-to-one ratio so that a slight change in patient condition would be detected before the patient
became hypercapnic. Therefore, hypercapnic episodes had been low throughout this study.
However, capnography monitoring among the capnography group allowed for earlier detection
of hypotension, hypoxia, and decreased sedation (Table 3). None of the patients in the
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capnography group required naloxone; instead, nursing interventions (stopping or decreasing the
PCA dose and re-positioning) reversed the effects of the opioids while maintaining adequate pain
control. As the intent of this project is to eventually implement capnography monitoring on the
non-ICU medical units, and nursing care is not provided one-to-one for the most part, the true
benefit of capnography monitoring is yet to be determined.
Eligibility for inclusion into the study may also have impacted results. As the ICU also
admits children (defined as younger than 18 years), the nursing and medical staff observed that
some teenagers may have benefited from capnography monitoring. These teenagers (ranging in
age from 15-17 years) had increased confusion, somnolence, hypoxia, or hypotension from the
opioids (epidural and intravenous). Inclusion of adolescents into the project may have
demonstrated that capnography would benefit this population too.
The last observation was difficulty with the nasal cannula equipment that was used for
ETCO2 monitoring. Nurses and respiratory therapists observed that as the nasal cannula became
moist with patient respiration, the cannula stopped detecting accurate ETCO2. The readings on
the modules displayed false readings of hypocapnia. The nasal cannula on patients needed
changing every eight to ten hours to continue to obtain accurate measurements. This resulted in
anecdotal decreased nurse satisfaction and could have a potential impact on implementation of
this project for the rest of the hospital.
For the institution in which this project was conducted, the recommendation is that
capnography monitoring should be used in patients receiving epidural or IV PCAs until stable
doses are reached for satisfactory pain control and the patient has been without hypotension,
hypoxia, decreased sedation level, bradypnea, or hypercapnia for at least 24 hours. Patients who
are receiving frequent, escalating doses of opioids, not on PCAs, can also benefit from
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capnography. Patient types who would most benefit from initial capnography include patients
older than 55 years, those on epidural opioids, females, and those with two or more comorbidities including obstructive sleep apnea, lung/cardiac disease, and a history of >20 pack
year smoking history. Although not a part of the sample for this project, teenagers aged 14-17
years may also benefit.
Plans for Sustainability and Future Scholarship
Vital sign machinery with capnography technology has been purchased for this institution.
There will now be the opportunity to perform capnography monitoring outside of the ICU.
Discussion among the Pain and Palliative Service, medical team and nursing leadership is
underway for the employment of capnography monitoring among patients who are considered
high risk for respiratory depression. Policies and procedures will need to be created. Nursing
and physician education will need to be developed. Integrating capnography monitoring as a
standard of practice will provide sustainability to this initiative.
Future directions with capnography monitoring at this institution include further defining
patients, including teenagers, who would profit from capnography. In addition, determining if
added equipment purchases are needed will require consideration. Future scholarship
opportunities include ongoing assessment of the benefit of capnography through auditing of
naloxone use in the institution, impact of capnography on alarm fatigue among nurses, and if
capnography results in improved patient satisfaction with pain management.
Conclusion
Randomized controlled trials have demonstrated that capnography monitoring in patients
receiving opioids can be beneficial in detecting early respiratory compromise before adverse

CAPNOGRAPHY IMPLEMENTATION

31

outcomes occur. This project was limited by the small sample size and ICU level care patients
received. However, observable results from this project suggested that capnography monitoring
may be most useful in patients 55 or older, those receiving epidural opioids, and those with
multiple co-morbidities including smoking history, obstructive sleep apnea, and lung and/or
cardiac disease. Teenagers may also benefit from capnography based on anecdotal observation.
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Appendix A

{Attributes of the organization}

Internal Origin

SWOT Analysis










Helpful

Harmful

To achieving the objective

To achieving the objective

Strengths

Weaknesses

Stakeholder involvement
Commitment of leadership in
all departments
A commitment to providing
excellent clinical care
Employee engagement
Nursing shared governance
Strong nursing education
department
Strong CNS group
New vital sign equipment
purchase





{Attributes of the organization}

External Origin

Opportunities








Accreditation and survey by
outside organizations
concerned with patient safety
Wanting to bring NIH up to
highest clinical practice
standards
Influx of new personnel who
have practiced in the
community and are
knowledgeable about best
practices
Defining a high-risk patient
based on research

Budgetary constraints
Outdated clinical knowledge due to
“institutialization” of researchers.
No central telemetry monitoring on
each unit that admits patients with
PCAs

Threats






Unwillingness to change culture in
some areas of the NIH
Cybersecurity concerns about the
capnographic equipment
Consensus on the clear definition of
who a high-risk patient would be who
would require capnography
Attitude by some that research
outweighs clinical care
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Appendix B
Evidence Table

Although ETC
detected hypoxia
earlier than pulse
oximetry alone, it
did not make a
difference as far
as clinical

Evidence Level
& Quality

Monitoring during
procedural sedation
using standard of care
which consisted of
continuous oxygen
delivery, pulse
oximetry and cardiac
monitoring, and blood
pressure measurement
every 5 minutes

Patients in the end
tidal capnopmetry
(ETC) group had
more use of
airway
repositioning
maneuvers and
hypotension

There was no
difference in
patients
experiencing desaturation
(SaO2<90%)
between the two
groups; however,
patients in the
ETC group were
more likely to
require airway
repositioning
(12.9% vs. 9.3%,
P=0.003).
Hypotension
(SBP<100
mmHg or <85
mmHg if
baseline <100
mmHg) was
observed in 16

Limitations

Control Group:

Control and
intervention
groups were
similar in
demographics and
sedatives used

Observable
Measures

Patients receiving
procedural sedation and
analgesia in an
emergency department
including orthopedic
manipulation,
cardioversion, and
abscess incision and
drainage.

Study findings
that help
answer the
EBP Question

Randomized
Controlled Trial

Sample,
Sample Size,
Setting

Campbell, S.,
Magee, K., Zed,
P., Froese, P.,
Etsell, G.,
LaPierre,
A….Petrie, D.
(2016).

Evidence Type

Author & Date

Article #
1

Limitations:

Level I

Conducted in a
real-world
setting.
No
standardized
sedative
regimen used
Not blinded

BGood
quality
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Intervention Group:
Standard of care (as
above) plus continuous
end tidal CO2
monitoring which was
recorded every 5
minutes

outcomes in this
trial
Conclusion: Use
of capnography
did not improve
clinical outcomes
for patients
receiving sedation
in the ED

(3.3%) patients
in the ETC group
and 7 (1.4%) in
the control group
(P=0.048).

Total: 986
Control: 501
Intervention:
485

2

Deitch, K.,
Miner, J.,
Chudnofsky, C.,
Dominici, P.
and Latta, D.
(2010).

Randomized
Controlled Trial

Patients receiving
propofol in an ED
Control Group:
Standard monitoring
which included pulse
oximetry, cardiac
monitoring, blood
pressure monitoring
plus capnography that
MDs could monitor

Intervention Group:

Capnography
provides early
warning of
respiratory
depression

Both control and
blinded
capnography
groups equal in
demographics,
dosing of
propofol,
diagnosis
(drainage of
abscess, joint
reduction, and
fracture
reduction),
Ramsey scores

Limitations:

Level
I

Higher than
expected
Adisqualification High
rate
quality
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Standard monitoring as
above but MDs could
not visualize the
capnometer

Total: 132
Control Group
(capnography): 68

Intervention (blinded
capnography group):
64
screen

and time to
recovery
Respiratory
depression rates
similar between
groups
Hypoxia was
more frequent in
the blinded
capnography
group (42% in
blinded
capnography as
compared to 25%
in capnography
group)
Physician
interventions to
improve
respiratory status
more frequent in
the capnography
group (35% vs
22% in blinded
group)
Capnography use
decreased the
rate of hypoxic
events by 17%
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Friedrich-Rust,
M., Welte, M.,
Albert, J.,
Meckbach, Y.,
Hermann, E.,
Kannennglesser,
M…..Bojunga,
J. (2014).

Randomized
Controlled Trial
conducted at two
centers

39
Patients receiving
Use of
propofol for
capnography
endoscopy/colonoscopy decreased
incidence of
Control Group:
hypoxemia
Standard care with
continuous pulse
oximetry, cardiac
monitoring (some
patients), 2l O2, blood
pressure measurement
every 3 minutes and
clinical observation
Intervention Group:
Standard care plus
capnography

Total: 533
Control: 266
Intervention: 267

Hypoxemia
occurred less in
the capnography
group compared
to standard care
group (18% vs.
32%)
Time between
detection of
apnea and
hypoxemia was
22 seconds in the
capnography
group
Severe hypoxia
occurred in 6%
of capnography
group vs 8% of
standard group
No difference
between groups
in need for
assisted
ventilation,
hypotension or
bradycardia

Limitations of
study:

Level
I

Different
sedative
regimens used
at both centers
Patients who
received
endoscopy
were not in the
blinded arm

AHigh
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Gupta, K.,
Prasad, A.,
Nagappa, M.,
Wong, J.,
Abrahamyan,
L., & Chung, F.
(2018).

Systematic
Review

40
Primary objective of
this study is to review
and summarize the risk
factors of OIRD in the
postoperative period
N: 13 studies
871,912 total number
of surgical patients
over 10 studies

Monitoring of
sedation level,
pulse oximetry
and capnography
is recommended
in patients at risk
of opioid induced
respiratory
depression
(OIRD)

Incidence of
OIRD varies
from 0.1 to
23.7%
Preoperative
gabapentin or
sustained release
oxycodone was
found to be a
contributory
factor of OIRD.
Out of the
871,912 post- op
patients, 4337
patients acquired
postoperative
OIRD, with a
prevalence of
0.5%
Predominantly
OIRD occurred
mostly within the
first 24 hours
after surgery (in
PACU), with a
predominance in
a the first 12 h.
The mean age of
patient with
OIRD was
greater than 60
years in eight
studies and
greater than 50
years in three
studies.

Limitations:
Staffing ratios
Training and
education of
staff to
implement
changes in
practice.
Cost of new
equipment
needed to
implement
capnography
and other
monitoring.

Level
I
A/BGood
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In nine studies, a
higher proportion
(50-60%) of
women were
reported to have
OIRD.
The following
comorbidities
were identified to
be associated
with a higher risk
of OIRD:
Obstructive sleep
apnea (OSA)
Chronic
obstructive
pulmonary
disease (COPD)
cardiac disease
diabetes mellitus
hypertension
neurologic
disease (stroke,
dementia)
renal disease
obesity-two or
more
comorbidities
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-opioid
dependence
8. In Weingarten
et al. reported
that general
anesthesia was
significantly
associated with a
higher incidence
of OIRD (312
per 1000 cases)
compared with
neuraxial
anesthesia (144
per 1000 cases).
9. In Lee et al.
closed claim’s
analysis, OIRD
was associated
with
administration of
morphine in 64%
cases,
hydromorphone
in 25% cases and
fentanyl in 25%
of cases.
10. In Lee et al.
62% of patients
were deeply
sedated before
OIRD. In 31% of
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claims,
monitoring of
vital signs,
sedation levels
and pulse
oximetry by
nurses was
inadequate.

5

Jarzyna, D,
Jungquist, C.,
Pasero, C.,
Willens, J.,
Nisbet, A.,
Oakes,
L…Polomano,
R. (2011).

Position
Position statement for
Statement/Clinical nurses on monitoring
Guidelines
patients for opioid
induced respiratory
depression and sedation
by the American
Society for Pain
Management Nursing

Recommendations
developed based
on review of the
literature that
divided risk
factors of OIRD
into four
categories:
Individual risk
Iatrogenic risk
Pharmacology
Monitoring

The ASPM
developed
recommendations
based on
extensive review
of the literature,
external peer
review of the
applicability and
accuracy of the
literature.
Monitoring
practices,
education of
nurses, and
implementation
strategies were
included. Search
strategies for
literature was
included in this
article. The
American
Society of

Limitations:
Lack of RCTs
that examine
outcomes
associated with
monitoring
techniques
Lack of
standardized
definitions of
outcomes
across studies

Level
IV
A/BHigh
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Anesthesiologists
Evidence
Categories was
used to rate the
studies.

8

Li, M., Liu, Z.,
Lin, F., Wang,
H., Niu, X., Ge,
X…..Li, C.
(2018).

Randomized
Controlled Trial

Women receiving
propofol during
lumpectomy
Control Group:
Standard monitoring
(continuous pulse
oximetry, vital signs)
plus ETCO2
monitoring that
providers could
visualize

Intervention:
Providers blinded to
ETCO2 monitoring
Total: 188
Control: 94
Intervention: 94

Addition of
ETCO2
monitoring
improves patient
safety

CO2 retention
occurred less in
the monitored
group (10% vs
87%)
Number of
airway
interventions was
higher in the
control group vs
experimental
group (9.8 vs
1.2)
Apnea occurred
less often in the
control group vs
experimental
group (0 v 10%)
Recovery time
shorter in the
control group vs
experimental
group (9.9 min.
vs 11.4 min)

Limitations:
All participants
were women
Time needed
for CO2
recovery (use
of ABGs to
accurately
measure CO2)
was not
assessed due to
clinical need to
control
bleeding and
not cause
further pain

Level
I
BGood
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9

Mehta, P.,
Kochhar, G.,
Albedawi, M.,
Kirsh, B., Rizk,
M., Putka,
B……Vargo, J.
(2016).

Randomized
Controlled Trial

45
Use of capnography in
patients undergoing
endoscopy or
colonoscopy who
receive moderate
sedation

No statistical
difference in rates
of hypoxemia
detection between
the groups for
both arms

Control Group:
Capnography
visualized, and findings
verbalized to provider

There was no
signiﬁcant
difference in
rates of
hypoxemia
between the
blinded and open
capnography
arms for EGD
(54.1% vs. 49.5;
P =0.5) or
colonoscopy
(53.8 vs. 52.1%;

No
standardized
definition of
hypoxemia
Single
institution
study

Level
I

Further
research
should be

Level
II

AHigh
quality

Experimental Group:
P=0.79)
Capnography blinded
to provider
EGD Group Total: 208
Control: 101
Blinded Group: 108

Total Colonoscopy
Group: 231
Control: 117
Blinded: 114

10

Stites, M.,
Surprise, J.,
McNeil, J.,

Prospective
cohort study

Capnography use
Patients on PCA

Capnography
added benefit of
detecting opioid

Decrease in
percentage of
opioid-receiving
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Northrop, D.,
and Ruyter, D.
(2017).

46

Pre-intervention:
34,855

Post-intervention:
93,412

induced
respiratory
(OIRD) earlier
thus reducing RR
calls

patients
experiencing
OIRD in rapid
response from
0.04% preintervention (153
events in 34, 852
patients) to
0.02% post
intervention (200
events in 93,412
patients).
Statistically
significant
reduction in RR
calls associated
with IRD when
patients receiving
PCA were
monitored with
capnography

focused on risk
stratifying
patients to
determine
those who
would benefit
most from
additional
monitoring
Naloxone use
identified as
criteria for
inclusion into
study though
naloxone can
be used for
other
indications as
well
Alarm fatigue
identified by
nursing staff

AHigh
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Appendix C

Identification

PRISMA Diagram
Records identified through
PubMed, CINAHL, Google Scholar,
Web of Science and Medline
(n =820)

Additional records identified
through other sources
(n = 0)

Records screened
(n =37)

Records excluded
(n =118)

Full-text articles assessed
forAppendix
eligibility D
(n =37)

Full-text articles excluded,
with reasons
(n =29)


Eligibility

Screening

Records after duplicates removed
(n =155)



Studies included in
quantitative synthesis
(n = 8)



Included








Systematic reviews
(n=13)
Study described
operating room use
or resuscitative use
(n=10)
Study in French
(n=1)
Study described use
of ETCO2 for
endotracheal tube
placement (n=1)
Study described
capnography vs.
plethysmography in
children (n=1)
Study described use
in children during
tonsillectomy (n=1)
Pediatric studies
(n=2)
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Appendix D
Rosswurm and Larrabee Model
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Appendix E
Data Dictionary
Data Element

Data
Label
ID

Data Type

Definition/Purpose

Data Values & Coding

Numeric

Numeric

Age

Categorical

Gender

Gender

Categorical

Diagnosis

Primary
diagnosis

categorical

Comorbidities

COM

Categorical

Unique identifier
assigned by PI
Age of patient 55 years
or older OR less than
55 years
Biological gender from
EMR
Diagnosis of patient
that brought patient to
ICU
Number of comorbidities

Type of
opioid
prescribed
Capnography

OPI

Categorical

Route and type of
opioid

CAP

Categorical

Use of capnography
monitoring

Hypotension

HTN

Categorical

Blood pressure <90/60

0=no hypotension
1=hypotensive

Hypercapnia

HYC

Categorical

ETCO2 >45mmHg

Hypoxia

HYP

Categorical

Pulse oximetry <90%

Sedation level SED

Continuous

Level of sedation while
on PCA

Bradypnea

RR

Categorical

Adverse
Event

AE

Categorical

RR<12 breaths per
minute (bpm)
Type of AE that is
possibly attributed to
the PCA/opioid

0=no hypercapnia
1=hypercapnic
0=no hypoxia
1=hypoxic
0=alert/drowsy/easily aroused
1=sleeping/difficult to arouse
2=confused/hallucinating
3=unable to arouse
0=12-20 bpm
1=<12 bpm
0=no AE
1=AE

Patient
Identifier
Age in years

0= 55 or >
1=< 55
0=male
1=female
0=cancer
1=Immunodeficiency/transplant
2=Other
0=no co-morbidities
1=1 co-morbidity or smoker
(>20pack years), lung/cardiac
dz., and/or OSA
2=>2 co-morbidities including
above
0=epidural
1=IV PCA
2=high dose not IV or epidural
0=No capnography
1=capnography monitoring

CAPNOGRAPHY IMPLEMENTATION
Nursing
actions for
adverse
event

NA

Categorical

51
Type of nursing actions:
0. none
1. Hold PCA or
opioids
2. Repositioning
3. PCA settings or
narcotics
dosing
decreased
4. Rescue

0= none
1=Hold PCA or opioids
2=Repositioning
3=PCA settings or narcotics
dosing decreased
4=Rescue, including naloxone
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Appendix F
Decision Tree
Patient admitted with PCA or requires
frequent, escalating doses of opioids
for pain control AND is considered
high-risk for respiratory depression

High-risk criteria:
1. PCA
2. Use of two or more opioids
or adjunct agents
simultaneously
3. Frequent escalating doses
of opioids (patients not on
PCAs)
4. Concern by medical or
nursing staff that patient at
risk for respiratory
depression

Yes

No

Monitoring as per policy:
Place patient on capnography

Document assessment in
EMR
Hourly ETCO2 reading
documented in EMR (if
applicable)





Vitals hourly
Sedation hourly
Pain assessment as
per Nursing Policy
(at least every 4
hours)

Continue to monitor
for capnography need

Ongoing data collection for
determination of accuracy of criteria
defining high-risk
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Appendix G
Table 1: Descriptive Characteristics of the Patients
Characteristics

Standard Monitoring

Capnography Monitoring

58.1 (+ 18)

59.7 (+ 15)

Male

60%

50%

Female

40%

50%

Cancer

80%

70%

Immunodeficiency/
transplant

10%

20%

Other

10%

10%

None

50%

10%

One COM or smoker,
lung/cardiac disease, OSA

10%

40%

40%

50%

Epidural PCA

40%

70%

IV PCA

60%

20%

High dose opioids

0%

10%

Age
Gender

Primary Diagnosis

Number of co-morbidities
(COM)

Two or more COM plus
Above
Opioid Type

CAPNOGRAPHY IMPLEMENTATION

54

Appendix H
Table 2: Comparison of Capnography Monitoring and Number of Adverse Patient Events
Capnography
Events

N

Adverse
N

Chi Square Statistics
df
N p
X2
%

No capnography

10

3

30%

Capnography

10

3

30%

Total

20

6

30%

1

20 1.00

0.00

CAPNOGRAPHY IMPLEMENTATION

55

Appendix I
Table 3: Percentage of patients with monitoring events
Monitoring Event

Standard Monitoring

Capnography Monitoring

Systolic BP<90/60
Yes

10%

20%

No

90%

80%

ETCO2>45
Yes

N/A

30%

No

N/A

70%

Yes

10%

30%

No

90%

70%

70%
30%

80%
20%

Alert/oriented

90%

80%

Difficult to arouse

10%

0%

Confused hallucinating

0%

10%

Unable to arouse

0%

10%

SpO2<90

Respiratory Rate
12-20 breaths per minute
<12 breaths per minute
Sedation Level
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Appendix J
Table 4: Comparison of Adverse Events with Age, Gender, Number of Co-morbidities, Opioid Type and
Diagnosis
N=20

Variable
Age
55 or older
< 55
Gender
Male
Female
Number of Co-morbidities
(COM)
None
One COM or > 20py
smoking or lung/cardiac disease
and/or OSA
Two COM + above
Opioid Type
Epidural
IV PCA
High dose not epidural or IV
PCA

Adverse Event
(percentage)

Df

p

Chi-Square
Statistic (X2)

30%
0%

1

.091

2.857

10%
20%

1

.202

1.626

5%
5%

2

.440

1.640

2

.241

2.846

2

.240

2.857

20%
25%
5%
0%

Diagnosis
Cancer
Immunodeficiency/transplant

30%
0%

Other

0%

